We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

JEOL

JEOL is a leading global supplier of electron microscopes, ion beam instruments, mass spectrometers and NMR spectrome... read more Featured Products: More products

Download Mobile App





JEOL Ltd. Introduces BioMajesty Series of Clinical Chemistry Analyzers at MEDICA 2019

By LabMedica International staff writers
Posted on 18 Nov 2019
JEOL Ltd. More...
(Tokyo, Japan) introduced its BioMajesty series of clinical chemistry analyzers featuring unique but proven technologies at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 18-21 November in Düsseldorf, Germany. At the 2019 edition of MEDICA, more than 5,000 exhibitors from 70 countries presented their newest products and ideas. The event also drew more than 120,000 trade visitors from over 170 countries.

JEOL offers the BioMajesty series of clinical chemistry analyzers which use micro volume of samples and reagents to deliver highly-accurate, high-speed processing through the incorporation of a sample dilution tray, which is an outstanding unique feature of all BioMajesty analyzers.

At the 2019 edition of MEDICA, JEOL showcased its BioMajesty series of clinical chemistry analyzers, which include the JCA-ZS050, JCA-BM6070/C and JCA-BM6010/C. The JCA-ZS050 clinical chemistry analyzer is bolstered by the breakthrough technology and unique dilution mechanism of the series. The JCA-ZS050 boasts of extra-micro-volume measurement with minimum 40μL reaction volume. The 1,800 throughput/hour next-generation chemistry analyzer from JEOL brings innovative operation and simple maintenance, while assuring high-precision data empowered by its novel wash mechanism.

The JCA-BM6070/C clinical chemistry analyzer has 2,400 tests/hour throughput, achieving unprecedented ultrafast processing capability in the 2.0-second cycle time. While realizing minimum reaction volume of 60μl by its unique pre-dilution mechanism, it offers high data reliability and excellent cost benefits.

The JCA-BM6010/C is a compact, reliable chemistry system with versatile functions, offering a maximum throughput of 800 tests/hour for photometry and 1,200 tests/hour with ISE. Bolstered by unique micro-volume technology, a strong tradition of BioMajesty series, it streamlines the daily laboratory routine by automatic on-board hemolysis for HbA1c. The JCA-BM6010/C’s0 superior usability with STAT port and Smart Pause/Smart Start features in its optimized space-saving design help deliver more flexibility.

Related Links:
JEOL Ltd.


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Chemistry System
P780
New
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.